Roquinimex is a prescription medication used to treat rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. It is a biologic medication made from a type of protein called a monoclonal antibody. Roquinimex targets and blocks the action of a protein called tumor necrosis factor (TNF)-alpha, which is involved in inflammation. This can help reduce inflammation and pain associated with these conditions. Roquinimex is given as an injection under the skin or into a vein. Common side effects include injection site reactions, upper respiratory infections, and headache
Roquinimex, also known by its generic name Linomide, is a medication that is being investigated for its potential to treat a number of cancers and autoimmune conditions. It works by stimulating the immune system and inhibiting the growth of blood vessels that tumors need to grow.
Here's a summary of what Roquinimex does:
- Immunostimulant: It increases the activity of natural killer (NK) cells and macrophages, which are important for fighting cancer and infections.
- Inhibits angiogenesis: It blocks the formation of new blood vessels, which can starve tumors of the oxygen and nutrients they need to grow.
- Reduces TNF alpha: It lowers levels of a protein called tumor necrosis factor alpha (TNF-alpha), which can be involved in inflammation and autoimmune diseases.
Clinical trials for Roquinimex have been conducted, but some have been terminated due to serious cardiovascular side effects. More research is needed to determine if this medication is safe and effective for long-term use.
Important to note:
- Roquinimex is not currently approved by the FDA or any other regulatory agency for the treatment of any medical condition.
- It should only be taken under the supervision of a doctor who is familiar with the potential risks and benefits of this medication.